Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,950,119
-
Total 13F shares
-
76,353,881
-
Share change
-
+1,361,325
-
Total reported value
-
$1,424,754,261
-
Put/Call ratio
-
18%
-
Price per share
-
$18.66
-
Number of holders
-
170
-
Value change
-
+$29,258,598
-
Number of buys
-
87
-
Number of sells
-
70
Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q1 2023
As of 31 Mar 2023,
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) was held by
170 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
76,353,881 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Point72 Asset Management, L.P., FIRST TRUST ADVISORS LP, BAKER BROS. ADVISORS LP, ARMISTICE CAPITAL, LLC, GEODE CAPITAL MANAGEMENT, LLC, and SCHRODER INVESTMENT MANAGEMENT GROUP.
This page lists
170
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.